More than 40 years ago, Apollonia Kotero met Prince when she auditioned to play his love interest in 1984’s Purple Rain. She landed the part, and he named the character in the semi-autobiographical musical film after her. Now the actress, whose full name is Patricia Apollonia Kotero, is suing the late singer’s estate, Paisley Park […]

"When I am lying in bed waiting for an acute flare-up of nausea to subside, I feel so depressed that I can’t help wondering if I can continue to live this way."

Serena Williams has just publicly admitted to using GLP-1 medication for weight loss. The 23-time Grand Slam champion says she used a weight loss drug to help her drop 31 pounds, after being encouraged by fans for months to share what helped her transform her body.

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the semaglutide.

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This raises significant concerns for older adults, who are already at risk for muscle loss and reduced mobility.

A host of women have complained that they are experiencing 'Ozempic vulva' after taking weight loss drugs to shed the pounds.

Taking meds to lose weight has been surging among Americans. While these drugs are safe, they have one drawback, they can also cause muscle mass loss.

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed by Long Islanders.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

From tiny plates to mini martinis, this is how menus are being shaped by a weight-loss era - FOOD FOCUS: From luxe mini menus to teeny tiny tasting formats, restaurants are rewriting the rules in response to their customers on weight-loss drugs like Ozempic and Mounjaro.